Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey†

Abstract

To ensure the safety of irinotecan therapy, it is important to select appropriate patients by considering the risk factors.